Market Place
Sourcing Support
All News #Library
Biotech
Dyne Therapeutics To Participate In Upcoming Investor Conferences
25 Feb 2026 //
GLOBENEWSWIRE
Dyne Therapeutics To Present At J.P. Morgan Healthcare Conference
07 Jan 2026 //
GLOBENEWSWIRE
Dyne Therapeutics Plans Public Stock Offering
08 Dec 2025 //
GLOBENEWSWIRE
Dyne Therapeutics Unveils Q3 2025 Financials & Business Updates
05 Nov 2025 //
GLOBENEWSWIRE
Dyne Reports 1-Year Ph1/2 ACHIEVE Data Of DYNE-101 In DM1
06 Oct 2025 //
GLOBENEWSWIRE
Dyne Therapeutics Appoints Brian Posner To Its Board Of Directors
02 Oct 2025 //
GLOBENEWSWIRE
Dyne Therapeutics Reports Q1 2025 Financial Results & Highlights
08 May 2025 //
GLOBENEWSWIRE
Dyne Therapeutics Reveals Long-Term Data from DYNE-251 Trial
16 Mar 2025 //
GLOBENEWSWIRE
Dyne Receives FDA Fast Track For DYNE-101 In Myotonic Dystrophy
21 Jan 2025 //
GLOBENEWSWIRE
Dyne Reports DYNE-101 Data, Expansion For DM1 US Approval In 2026
10 Jan 2025 //
GLOBENEWSWIRE
Dyne To Present At Chardan Genetic Medicines Conference
23 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.